G01N 2333/163
Regulatory proteins
Official title: Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx
G01N2333/163 (Regulatory proteins) appears on 140 US grants and 89 published applications in this corpus.
Search patents in G01N- Granted patents
- 140
- Published applications
- 89
- Assignees
- 50
- Inventors
- 158
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 20 | 0 |
| 1998 | 30 | 0 |
| 1999 | 8 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 0 |
| 2002 | 5 | 5 |
| 2003 | 4 | 13 |
| 2004 | 6 | 14 |
| 2005 | 2 | 8 |
| 2006 | 7 | 7 |
| 2007 | 2 | 4 |
| 2008 | 2 | 5 |
| 2009 | 2 | 2 |
| 2010 | 1 | 2 |
| 2011 | 4 | 4 |
| 2012 | 0 | 3 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 0 | 3 |
| 2016 | 1 | 2 |
| 2017 | 3 | 3 |
| 2018 | 0 | 1 |
| 2019 | 2 | 2 |
| 2020 | 3 | 4 |
| 2021 | 2 | 1 |
| 2022 | 2 | 2 |
| 2023 | 2 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Exosome-mediated diagnosis of hepatitis virus infections and diseases6 Jan 2026US 12,517,129 B2Morehouse School of Medicine
- Methods of identifying HIV patients sensitive to therapy with GP120 V3 glycan-directed antibodies1 Oct 2024US 12,102,677 B2Gilead Sciences, Inc.
- Silica-based biomolecule carrier, pharmaceutical composition comprising the same, preparation method and use thereof6 Jun 2023US 11,666,662 B2National Taiwan University
- Compounds inhibiting Nef-calnexin interaction24 Jan 2023US 11,561,217 B2The George Washington University
- Exosome-mediated diagnosis of hepatitis virus infections and diseases14 Jun 2022US 11,360,090 B2Morehouse School of Medicine
- Methods of identifying hiv patients sensitive to therapy with gp120 v3 glycan-directed antibodies6 Feb 2025US 2025/0041401 A1Gilead Sciences, Inc.
- Tat peptide binding proteins and uses thereof2 Mar 2023US 2023/0061973 A1Larimar Therapeutics, Inc.
- Exosome-mediated diagnosis of hepatitis virus infections and diseases1 Sep 2022US 2022/0276248 A1Morehouse School of Medicine
- Exosome-mediated diagnosis of hepatitis virus infections and diseases11 Aug 2022US 2022/0252600 A1Morehouse School of Medicine
- Compounds inhibiting nef-calnexin interaction30 Dec 2021US 2021/0405029 A1The George Washington University
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997
- High-affinity nucleic acid ligands that discriminate between theophylline and caffeine277US 5,580,737 ANeXstar Pharmaceuticals, Inc. · 1996